Sonoma Pharmaceuticals Investor Presentation April 2024

Sonoma Pharmaceuticals develops and manufactures stabilized hypochlorous acid (HOCl) products for wound, eye, oral, nasal care, dermatology, and animal health applications. The company's clinically proven products are designed to reduce itch, pain, scarring, and irritation while safely managing skin injuries across 55 countries worldwide.